BRVO - Branch Retinal Vein Occlusion: Clinical Trials

3 trials for BRVO - Branch Retinal Vein Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 2 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1
Phase 11Completed 1
Phase 21Completed 1

Follow BRVO - Branch Retinal Vein Occlusion: new trials by email Literature Review of BRVO - Branch Retinal Vein Occlusion trials Research Report on BRVO - Branch Retinal Vein Occlusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
EYE201 - Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD)
Phase 1 / Phase 2CompletedEyeBiotech Ltd.382024-11-122026-08-24
A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
bevacizumab - Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration
Phase 3Active not recruitingOutlook Therapeutics, Inc.1202021-11-152026-04-22
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
bevacizumab - Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration
Phase 3CompletedOutlook Therapeutics, Inc.1972020-10-012026-07-17

Narrower conditions

Retinal Vein Occlusion (3)  ·  Macular Degeneration (2)  ·  Wet Macular Degeneration (2)

Broader conditions

Cardiovascular Diseases (3)  ·  Embolism and Thrombosis (3)  ·  Eye Diseases (3)  ·  Retinal Diseases (3)  ·  Thrombosis (3)  ·  Vascular Diseases (3)  ·  Venous Thrombosis (3)  ·  Retinal Degeneration (2)

Interventions

Bevacizumab (2)

Sponsors

Outlook Therapeutics, Inc. (2)  ·  EyeBiotech Ltd. (1)

Countries

United States (3)  ·  Puerto Rico (1)